Interlace launches MyoSure trial

March 30, 2010 by MassDevice staff

Interlace Medical launches a clinical trial of its MyoSure fibroid surgery device.

Interlace Medical logo

Interlace Medical Inc. launched a clinical trial of its MyoSure fibroid surgery device, aiming to prove that women experience little pain or discomfort during the procedure.

The Framingham, Mass.-based firm's myomectomy system is a minimally invasive technique that allows for the removal of submucosal fibroids and polyps in a single, out-patient procedure. Submucosal fibroids are benign tumors that grow just beneath the endometrial lining of the uterus.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.


Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp